Background Pulmonary hypertension (PH) medical therapies are commonly used as a bridge to balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic PH (CTEPH) but their effectiveness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results